Rheumatoid Arthritis Research Today is a free monthly online journal that collates and summarizes the latest research about Rheumatoid Arthritis, including details on treatment, symptoms, causes, medication.

Volume 6 (2009), Issue 9 (September)

1. Total shoulder replacement in rheumatoid disease: a 16- to 23-year follow-up.
   J Bone Joint Surg Br, 91(9): 1197-200. [Abstract] [Full-text]
2. Hypothetical hormonal mechanism by which potassium-rich diets benefit patients with rheumatoid arthritis.
   Med Hypotheses, 73(4): 564-8. [Abstract] [Full-text]
3. Association of UCP2 -866 G/A polymorphism with chronic inflammatory diseases.
   Genes Immun, 10(6): 601-5. [Abstract] [Full-text]
4. Small interfering RNA targeting CD81 ameliorated arthritis in rats.
   Biochem Biophys Res Commun, 388(3): 467-72. [Abstract] [Full-text]
5. Assessing quality of sleep in patients with rheumatoid arthritis.
   J Rheumatol, 36(9): 2077-86. [Abstract] [Full-text]
6. Plasma adiponectin in patients with active, early, and chronic rheumatoid arthritis who are steroid- and disease-modifying antirheumatic drug-naive compared with patients with osteoarthritis and controls.
   J Rheumatol, 36(9): 1885-91. [Abstract] [Full-text]
7. Th17 transcription factor RORC2 is inversely correlated with FOXP3 expression in the joints of children with juvenile idiopathic arthritis.
   J Rheumatol, 36(9): 2017-24. [Abstract] [Full-text]
8. Palindromic rheumatism: longterm outcomes of 60 patients diagnosed in 1967-84.
   J Rheumatol, 36(9): 1873-5. [Abstract] [Full-text]
9. Comparison of patients with juvenile psoriatic arthritis and nonpsoriatic juvenile idiopathic arthritis: how different are they?
   J Rheumatol, 36(9): 2033-41. [Abstract] [Full-text]
10. Does sonographic needle guidance affect the clinical outcome of intraarticular injections?
    J Rheumatol, 36(9): 1892-902. [Abstract] [Full-text]
11. Can magnetic resonance imaging differentiate undifferentiated arthritis based on knee imaging?
    J Rheumatol, 36(9): 1963-70. [Abstract] [Full-text]
12. Purified protein derivative response in juvenile idiopathic arthritis.
    J Rheumatol, 36(9): 2029-32. [Abstract] [Full-text]
13. Do rheumatoid arthritis patients have a higher risk for sleep apnea?
    J Rheumatol, 36(9): 1869-72. [Abstract] [Full-text]
14. The association with the -159C/T polymorphism in the promoter region of the CD14 gene and juvenile idiopathic arthritis in a Chinese Han population.
    J Rheumatol, 36(9): 2025-8. [Abstract] [Full-text]
15. Association of severe inflammatory polyarthritis in primary Sjögren's syndrome: clinical, serologic, and HLA analysis.
    J Rheumatol, 36(9): 1937-42. [Abstract] [Full-text]
16. Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects.
    Medicine (Baltimore), 88(5): 284-93. [Abstract] [Full-text]
17. Monitoring anti-TNFalpha treatment in rheumatoid arthritis: responsiveness of magnetic resonance imaging and ultrasonography of the dominant wrist joint compared with conventional measures of disease activity and structural damage.
    Ann Rheum Dis, 68(10): 1572-9. [Abstract] [Full-text]
18. Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study.
    Ann Rheum Dis, 68(10): 1580-4. [Abstract] [Full-text]
19. Erosive progression is minimal, but erosion healing rare, in patients with rheumatoid arthritis treated with adalimumab. A 1 year investigator-initiated follow-up study using high-resolution computed tomography as the primary outcome measure.
    Ann Rheum Dis, 68(10): 1585-90. [Abstract] [Full-text]
20. Progression of radiographic joint damage in rheumatoid arthritis: independence of erosions and joint space narrowing.
    Ann Rheum Dis, 68(10): 1535-40. [Abstract] [Full-text]
21. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and primary Sjögren syndrome: a comparative population-based study.
    Ann Rheum Dis, 68(10): 1541-6. [Abstract] [Full-text]
22. Influence of variants of Fc gamma receptors IIA and IIIA on the American College of Rheumatology and European League Against Rheumatism responses to anti-tumour necrosis factor alpha therapy in rheumatoid arthritis.
    Ann Rheum Dis, 68(10): 1547-52. [Abstract] [Full-text]
23. A systematic review and meta-analysis of the efficacy and safety of etanercept for treating rheumatoid arthritis.
    Scand J Immunol, 70(4): 337-44. [Abstract] [Full-text]
24. Depletion of B lymphocytes in rheumatoid arthritis patients modifies IL-8-anti-IL-8 autoantibody network.
    Clin Immunol, 133(1): 108-16. [Abstract] [Full-text]
25. Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activity.
    Rheumatology (Oxford), 48(10): 1323-7. [Abstract] [Full-text]
26. Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies.
    Rheumatology (Oxford), 48(10): 1309-13. [Abstract] [Full-text]
27. The effect of etanercept on work productivity in patients with early active rheumatoid arthritis: results from the COMET study.
    Rheumatology (Oxford), 48(10): 1283-9. [Abstract] [Full-text]
28. Usefulness of initial histological features for stratifying Sjogren's syndrome responders to mizoribine therapy.
    Rheumatology (Oxford), 48(10): 1279-82. [Abstract] [Full-text]
29. Geriatric syndromes in elderly patients with rheumatoid arthritis.
    Rheumatology (Oxford), 48(10): 1261-4. [Abstract] [Full-text]
30. Factors associated with fatal outcome of leflunomide-induced lung injury in Japanese patients with rheumatoid arthritis.
    Rheumatology (Oxford), 48(10): 1265-8. [Abstract] [Full-text]
31. Methotrexate therapy in rheumatoid arthritis after failure to sulphasalazine: to switch or to add?
    Rheumatology (Oxford), 48(10): 1247-53. [Abstract] [Full-text]
32. Residual minimal disease activity in rheumatoid arthritis: a simple definition through an in-depth statistical analysis of the major outcome.
    Rheumatology (Oxford), 48(10): 1242-6. [Abstract] [Full-text]
33. Medico-economic evaluation of infliximab in rheumatoid arthritis--prospective French study of a cohort of 635 patients monitored for two years.
    Rheumatology (Oxford), 48(10): 1236-41. [Abstract] [Full-text]
34. Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit?
    Rheumatology (Oxford), 48(10): 1185-9. [Abstract] [Full-text]
35. TNF-alpha antagonist survival rate in a cohort of rheumatoid arthritis patients observed under conditions of standard clinical practice.
    Ann N Y Acad Sci, 1173: 837-46. [Abstract] [Full-text]
36. Effects of biologics on vascular function and atherosclerosis associated with rheumatoid arthritis.
    Ann N Y Acad Sci, 1173: 814-21. [Abstract] [Full-text]
37. B cell depletion in early rheumatoid arthritis: a new concept in therapeutics.
    Ann N Y Acad Sci, 1173: 729-35. [Abstract] [Full-text]
38. Rituximab therapy in primary Sjögren's syndrome.
    Ann N Y Acad Sci, 1173: 701-5. [Abstract] [Full-text]
39. Long-term effects of rituximab in rheumatoid arthritis: clinical, biologic, and pharmacogenetic aspects.
    Ann N Y Acad Sci, 1173: 692-700. [Abstract] [Full-text]
40. Genetic susceptibility loci in rheumatoid arthritis establish transcriptional regulatory networks with other genes.
    Ann N Y Acad Sci, 1173: 521-37. [Abstract] [Full-text]
41. Association of polymorphisms in interleukin-10 gene promoter with autoantibody production in patients with rheumatoid arthritis.
    Ann N Y Acad Sci, 1173: 501-8. [Abstract] [Full-text]
42. Immmunopathogenesis of rheumatoid arthritis; induction of arthritogenic autoimmune responses by proinflammatory stimuli.
    Ann N Y Acad Sci, 1173: 391-400. [Abstract] [Full-text]
43. Sex differences in a murine model of Sjögren's syndrome.
    Ann N Y Acad Sci, 1173: 378-83. [Abstract] [Full-text]
44. Alterations in cytokine profile and dendritic cells subsets in peripheral blood of rheumatoid arthritis patients before and after biologic therapy.
    Ann N Y Acad Sci, 1173: 334-42. [Abstract] [Full-text]
45. CXCR3, inflammation, and autoimmune diseases.
    Ann N Y Acad Sci, 1173: 310-7. [Abstract] [Full-text]
46. Autoimmune thyroid disease and autoimmune rheumatic disorders: a two-sided analysis.
    Ann N Y Acad Sci, 1173: 211-6. [Abstract] [Full-text]
47. Optimization of high-throughput autoantibody profiling for the discovery of novel antigenic targets in rheumatoid arthritis.
    Ann N Y Acad Sci, 1173: 92-102. [Abstract] [Full-text]
48. Atherosclerosis in rheumatoid arthritis versus diabetes: a comparative study.
    Arterioscler Thromb Vasc Biol, 29(10): 1702-8. [Abstract] [Full-text]
49. A pharmacodynamic Markov mixed-effects model for determining the effect of exposure to certolizumab pegol on the ACR20 score in patients with rheumatoid arthritis.
    Clin Pharmacol Ther, 86(4): 387-95. [Abstract] [Full-text]
50. The inhibitory Fc gamma IIb receptor dampens TLR4-mediated immune responses and is selectively up-regulated on dendritic cells from rheumatoid arthritis patients with quiescent disease.
    J Immunol, 183(7): 4509-20. [Abstract] [Full-text]
51. TRAF1 polymorphisms associated with rheumatoid arthritis susceptibility in Asians and in Caucasians.
    Arthritis Rheum, 60(9): 2577-84. [Abstract] [Full-text]
52. Outside-to-inside signaling through transmembrane tumor necrosis factor reverses pathologic interleukin-1beta production and deficient apoptosis of rheumatoid arthritis monocytes.
    Arthritis Rheum, 60(9): 2612-21. [Abstract] [Full-text]
53. Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis.
    Arthritis Rheum, 60(9): 2794-804. [Abstract] [Full-text]
54. Establishment of a matrix-associated transepithelial resistance invasion assay to precisely measure the invasive potential of synovial fibroblasts.
    Arthritis Rheum, 60(9): 2606-11. [Abstract] [Full-text]
55. Decline in rheumatoid vasculitis prevalence among US veterans: a retrospective cross-sectional study.
    Arthritis Rheum, 60(9): 2553-7. [Abstract] [Full-text]
56. Mathematical modeling of the circadian rhythm of key neuroendocrine-immune system players in rheumatoid arthritis: a systems biology approach.
    Arthritis Rheum, 60(9): 2585-94. [Abstract] [Full-text]
57. Evaluation of a novel 7-joint ultrasound score in daily rheumatologic practice: a pilot project.
    Arthritis Rheum, 61(9): 1194-201. [Abstract] [Full-text]
58. Does the weather really matter? A cohort study of influences of weather and solar conditions on daily variations of joint pain in patients with rheumatoid arthritis.
    Arthritis Rheum, 61(9): 1243-7. [Abstract] [Full-text]
59. Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis.
    Arthritis Rheum, 61(9): 1248-56. [Abstract] [Full-text]
60. Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7-induced immune activation in rheumatoid arthritis.
    Arthritis Rheum, 60(9): 2595-605. [Abstract] [Full-text]
61. Reevaluation of the interaction between HLA-DRB1 shared epitope alleles, PTPN22, and smoking in determining susceptibility to autoantibody-positive and autoantibody-negative rheumatoid arthritis in a large UK Caucasian population.
    Arthritis Rheum, 60(9): 2565-76. [Abstract] [Full-text]
62. Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis.
    Arthritis Rheum, 60(9): 2782-93. [Abstract] [Full-text]
63. Rheumatoid arthritis does not share most of the newly identified systemic lupus erythematosus genetic factors.
    Arthritis Rheum, 60(9): 2558-64. [Abstract] [Full-text]
64. The role of fractalkine as an accelerating factor on the autoimmune exocrinopathy in mice.
    Invest Ophthalmol Vis Sci, 50(10): 4753-60. [Abstract] [Full-text]
65. The minor salivary gland biopsy as a diagnostic tool for Sjogren syndrome.
    Laryngoscope, 119(10): 1922-6. [Abstract] [Full-text]
66. Deacetylase inhibition increases regulatory T cell function and decreases incidence and severity of collagen-induced arthritis.
    Exp Mol Pathol, 87(2): 99-104. [Abstract] [Full-text]
67. Rheumatoid synovial inflammation: pixel-by-pixel dynamic contrast-enhanced MR imaging time-intensity curve shape analysis--a feasibility study.
    Radiology, 253(1): 234-40. [Abstract] [Full-text]

© 2004-2012 Rheumatoid Arthritis Research Today. All Rights Reserved.